Abbott Laboratories Started Outperform by Oppenheimer Thanks to Favorable Risk/Reward By Investing.com
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE:) with an Outperform rating and a $130 price target in a ...
Investing.com -- Oppenheimer initiated coverage of Abbott Laboratories (NYSE:) with an Outperform rating and a $130 price target in a ...
Abbott Laboratories (New York Stock Exchange: ABT) shares are on track for their seventh consecutive session of gains, trading up ...
Every year, we share our 10 most read stories. Not surprisingly, many of this year's top 10 focused on equity, ...